• Lung cancer: Is a malignant tumor with an average five-year survival rate of 15%. Incidence is increasing due to an aging population and growing life expectancy.
• Costs: Lung cancer costs are rising, and have more than doubled in ten years time in the Netherlands (> 400m €). Diagnostic modalities can be very expensive (€ 45 -€ 1163) , therefore the diagnostic pathway should be examined thoroughly. We simulate the substitution of X-thorax with CT/VDT and the effect of the changing demographics in the Netherlands. Budget impact is based on 30000 patients.
CONCLUSIONS
• Otherwise comparable hospitals differ in the amount of diagnostic procedures used, suggesting different adherence to guidelines.
• Implementation of the low-dose CT with VDT instead of X-thorax leads to a gain of 0.39 QALY's and an average cost increase of € 212.25. The ICER is estimated to be € 538.99 per QALY.
• Budget impact will increase in the upcoming years due to an aging population. Smoking cessation will have a positive impact on budget impact. 
